BMY 45778
BMY 45778 is a non-prostanoid prostacyclin mimetic. BMY 45778 inhibits human (IC50 = 35 nM), rabbit (IC50: 136 nM) and rat (IC50 : 1.3 μM) platelet aggregation. BMY 45778 also activates adenylyl cyclase. BMY 45778 is a partial agonist at the prostacyclin receptor[1].
Product Specifications
CAS Number
152575-66-1
UNSPSC
12352005
Target
Adenylate Cyclase; Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bmy-45778.html
Purity
98.98
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(O)COC1=CC=CC(C2=C(C3=NC(C4=CC=CC=C4)=C(C5=CC=CC=C5)O3)N=CO2)=C1
Molecular Formula
C26H18N2O5
Molecular Weight
438.43
References & Citations
[1]Seiler SM, et al. [3-[4- (4,5-Diphenyl-2-oxazolyl) -5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Prostaglandins. 1997 Jan;53 (1) :21-35.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY433385 100 µg
XPNPEP1 (NM_001167604) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNC472715-500 1x 500 µL
PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus) (PAPPA/2715), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
